Cargando…

Anti-VEGF Treatment of Diabetic Macular Edema in Denmark: Incidence, Burden of Therapy, and Forecasting Analyses

Background: The aim of this study was to analyze demographically stratified incidence rates of patients with diabetic macular edema (DME) commenced in anti-VEGF therapy, to study temporal trends, to report the proportion of patients in active therapy over time, and to develop a model to forecast the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subhi, Yousif, Potapenko, Ivan, Hajari, Javad Nouri, la Cour, Morten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054899/ https://www.ncbi.nlm.nih.gov/pubmed/36983726 http://dx.doi.org/10.3390/jpm13030546

Ejemplares similares

Automated artificial intelligence‐based system for clinical follow‐up of patients with age‐related macular degeneration
por: Potapenko, Ivan, et al.
Publicado: (2022)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Artificial Intelligence-Based ChatGPT Responses for Patient Questions on Optic Disc Drusen
por: Potapenko, Ivan, et al.
Publicado: (2023)

Diabetic macular edema: it is more than just VEGF
por: Singer, Michael A., et al.
Publicado: (2016)

Vitreomacular interface after anti-VEGF injections in diabetic macular edema
por: Veloso, Carlos E., et al.
Publicado: (2021)

Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
por: Al-Halafi, Ali M
Publicado: (2015)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
por: Distefano, Laura N., et al.
Publicado: (2017)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022)

Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
por: Gonder, John R., et al.
Publicado: (2014)

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
por: Pfau, Maximilian, et al.
Publicado: (2021)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
por: Mira, Filipe, et al.
Publicado: (2017)

Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema
por: Huang, Wei-Hsuan, et al.
Publicado: (2021)

Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review
por: Wang, Patrick, et al.
Publicado: (2022)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
por: Choi, Moon Young, et al.
Publicado: (2019)

Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2021)

miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema
por: Vader, Maartje J. C., et al.
Publicado: (2021)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
por: Zhang, Ying, et al.
Publicado: (2022)

Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2022)

Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022)

Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema
por: Uwimana, Alexandre, et al.
Publicado: (2022)

The role of serum metrics in anti- VEGF treatment for macular edema induced by retinal vein occlusion
por: Wang, Yun-Chang, et al.
Publicado: (2023)

Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions
por: Boiko, Ernest V., et al.
Publicado: (2017)

Aqueous humor analyses of diabetic macular edema patients with subretinal fluid
por: Kwon, Jin-woo, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration in the Very Old (≥90 Years): Epidemiology, Adherence to Treatment, and Comparison of Efficacy
por: Subhi, Yousif, et al.
Publicado: (2017)

Correction: Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
por: Ruiz-Moreno, J. M., et al.
Publicado: (2020)

Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice
por: Urbančič, Mojca, et al.
Publicado: (2020)

Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
por: Bae, Young Hwan, et al.
Publicado: (2021)

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
por: Ahmedalgabri, Rayan Hamza Mohammed, et al.
Publicado: (2022)

Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema
por: Lin, Dan, et al.
Publicado: (2022)

The response of anti-VEGF therapy and tamoxifen withdrawal of tamoxifen-induced cystoid macular edema in the same patient
por: Li, Chuanyu, et al.
Publicado: (2021)

Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
por: Hong, Eun Hee, et al.
Publicado: (2022)

Effect of microaneurysms on the anti-VEGF treatment for diabetic macular edema: A retrospective cross-sectional study
por: Watanabe, Akira, et al.
Publicado: (2023)

Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
por: Yu, Lu, et al.
Publicado: (2023)

Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema
por: Elnahry, Ayman G., et al.
Publicado: (2020)

Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion
por: Tomita, Ryo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vgbj9g9igibv2ll416nj0tn9cd